Search results
Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 15 hours agoMany Bristol-Myers Squibb Company (NYSE:BMY) insiders ditched their stock over the past year, which...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via Yahoo Finance· 5 hours agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 2 days agoFisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent filing with the ...
Investors Purchase Large Volume of Bristol-Myers Squibb Put Options (NYSE:BMY)
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 69,538 put options on the company. This represents an increase of 76% compared ...
If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoIt's a reasonable question: If you'd invested $1,000 in pharmaceutical specialist Bristol Myers...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 17 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation
Morningstar· 3 days agoBy Colin Kellaher Bristol Myers Squibb on Monday said the Food and Drug Administration has accepted its application seeking approval of an subcutaneous formulation of its blockbuster cancer drug Opdivo. The Princeton, N.J., biopharmaceutical
Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a...
Simply Wall St. via Yahoo Finance· 5 days agoIt's easy to match the overall market return by buying an index fund. When you buy individual...
Bristol-Myers Squibb (NYSE:BMY) Given Average Rating of “Hold” by Analysts
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) has earned an average rating of “Hold” from the nineteen ratings firms that are currently covering the firm, MarketBeat.com reports. One research ...
Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
Motley Fool via Yahoo Finance· 6 days agoSome investors view growth or momentum stocks as the key to multi-bagger returns. Others prefer to...